| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |